Unit of Neurodegenerative Diseases, Department of Clinical Research in Neurology, University of Bari 'Aldo Moro', Tricase, Lecce, Italy.
Unit of Biostatistics, IRCCS 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Foggia, Italy.
Eur J Neurol. 2016 Jun;23(6):1117-25. doi: 10.1111/ene.12994. Epub 2016 Mar 25.
A strong association between time to generalization (TTG), considered as the time of spreading of the clinical signs from spinal or bulbar localization to both, and survival was recently identified in patients with amyotrophic lateral sclerosis (ALS). Thus, TTG may be used as an early to intermediate end-point in survival studies. The aim of the present study was to test TTG as a predictor of survival in ALS.
This was an observational retrospective study of ALS patients from a tertiary referral centre over a 5-year follow-up period.
In 212 ALS patients, TTG was associated with time to death/tracheostomy [R 0.62, 95% confidence interval (CI) 0.53-0.70; P < 0.001]. In a time-to-event analysis, longer TTG resulted in lower risk to reach a composite outcome (death or tracheostomy) both in univariate [hazard ratio (HR) 0.98, 95% CI 0.97-0.99] and multivariate Cox analyses (HR 0.98, 95% CI 0.96-0.99). TTG predicted death/tracheostomy at 4 years (C-statistic 0.58; 95% CI 0.53-0.63) and at 5 years (C-statistic 0.58; 95% CI 0.53-0.62).
Based on the present results from a large clinical cohort, TTG may be used as a new early to intermediate end-point to describe the ALS natural history. TTG may be potentially useful as a new primary outcome measure for clinical trials.
最近在肌萎缩侧索硬化症(ALS)患者中发现,从脊髓或延髓定位到双侧的临床体征扩散时间(TTG)与生存时间之间存在很强的关联。因此,TTG 可作为生存研究中的早期到中期终点。本研究旨在检验 TTG 作为 ALS 患者生存的预测因子。
这是一项在三级转诊中心进行的 ALS 患者的观察性回顾性研究,随访时间为 5 年。
在 212 例 ALS 患者中,TTG 与死亡/气管切开的时间相关[R 0.62,95%置信区间(CI)0.53-0.70;P < 0.001]。在生存时间分析中,TTG 较长时,在单变量和多变量 Cox 分析中,达到复合终点(死亡或气管切开)的风险较低[风险比(HR)0.98,95%CI 0.97-0.99]。TTG 可预测 4 年(C 统计量 0.58;95%CI 0.53-0.63)和 5 年(C 统计量 0.58;95%CI 0.53-0.62)时的死亡/气管切开。
基于本研究的大型临床队列结果,TTG 可作为描述 ALS 自然史的新的早期到中期终点。TTG 可能作为临床试验新的主要结局指标有用。